--------------------
human
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
--------------------
continue
AVGs
AVFs
Thrombosed
Thrombectomy
rheolytic
DCBs
--------------------
explain
hemoconcentration
Thrombosed
AVGs
AVFs
--------------------
create
AVGs
AVFs
rheolytic
--------------------
human
disease-2019
78%.5
CSDH)8
--------------------
continue
--------------------
create
disease-2019
--------------------
explain
treatmentsand
introducesthe
CSDH
--------------------
human
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
CD203a
ADPR
CD73
eADO
--------------------
create
adenosinergic
eADO
eATP
eATP
eADO
immunosurveillance
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
immunosurveillance
adenosinergic
--------------------
explain
immunoregulation
eATP
eATP
eATP
eADO
ectonucleotidases
eADO
CD39
CD73
eATP
CD203a
eADO
eADO
CD73
eADO
--------------------
continue
adenosinergic
eADO
eATP
eADO
eATP
eATP
eADO
eATP
eADO
immunosurveillance
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
--------------------
human
REF]).Detailed
sarcopenic
--------------------
continue
AgeiNg
ENHANce
sarcopenic
SarQoL
aLM
aLM
--------------------
explain
sarcopenic
sarcopenic
sarcopenic
--------------------
create
Jentoft
AgeiNg
ENHANce
ENHANce
sarcopenic
SarQoL
--------------------
explain
--------------------
human
PASC.The
https://recovercovid.org/protocols
PASC.The
--------------------
create
immunopathological
--------------------
continue
hyperinflammation
IL)-6
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
AVGs
AVFs
https://cdt.amegroups.com/article/view/10.21037/cdt-21-523/rc
AVGs
AVFs
rheolytic
hemoconcentration
Thrombectomy
AVGs
AVFs
AVGs
AVFs
AVGs
AVFs
Thrombectomy
rheolytic
AVGs
AVFs
disease-2019
78%.5
CSDH)8
disease-2019
disease-2019
CSDH
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
CD203a
ADPR
CD73
eADO
CD73
TNAP
eAMP
eADO
REF].Analogous
eATP
eADO
eADO
adenosinergic
eADO
eATP
eATP
eADO
adenosinergic
eATP
eATP
eADO
eATP
eADO
immunosurveillance
eATP
eADO
adenosinergic
adenosinergic
eATP
eADO
immunosurveillance
adenosinergic
eATP
eADO
eATP
eADO
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
eADO
eATP
CD39
CD73
CD39
eATP
CD73
eADO
eADO
CD203a
ADPR
CD203a
eADO
eADO
CD39
CD73
CD73
eADO
eADO
adenosinergic
eADO
adenosinergic
eATP
eADO
eATP
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
adenosinergic
eADO
eADO
CD39
CD73
eATP
eADO
eADO
adenosinergic
REF]).Detailed
sarcopenic
sarcopenic
sarcopenic
AgeiNg
ENHANce
sarcopenic
sarcopenic
sarcopenic
sarcopenic
sarcopenic
Jentoft
Jentoft
Biospecimens
PASC.The
https://recovercovid.org/protocols
PASC.The
IL)-6
hyperinflammatory
immunopathological
